炎症与认知障碍关系的研究进展

doi:10.3969/j.issn.1003-9198.2025.06.003

Abstract

Abstract: Cognitive dysfunction is a group of senile syndromes with high prevalence, which not only seriously affects the quality of life of elderly patients, but also brings heavy burden to society and family due to the lack of effective treatment. Clarifying the pathogenesis of cognitive impairment is a breakthrough point to seek early intervention. In recent years, numerous studies both at home and abroad have suggested that the pathogenesis of cognitive impairment may be related to inflammatory responses to some extent. Therefore, this article reviews the relationship between inflammation and multiple diseases accompanied by cognitive dysfunction.

Key words: inflammation, cognitive impairment, pathological mechanism

CLC Number:

CHANG Lin, GAO Yonghong. Research progress of inflammation and cognitive impairment[J]. Practical Geriatrics, 2025, 39(6): 547-550.

References

[1] 黄晓雯, 畅君雷. 外周炎症对血脑屏障功能的影响及其机制研究进展[J]. 生命科学, 2021, 33(1): 7-14.
[2] BELARBI K, CUVELIER E, BONTE M A, et al. Glycosphingolipids and neuroinflammation in Parkinson’s disease[J]. Mol Neurodegener, 2020, 15(1): 59.
[3] DHAPOLA R, HOTA S S, SARMA P, et al. Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease[J]. Inflammopharmacology, 2021, 29(6): 1669-1681.
[4] TIAN Z, JI X, LIU J. Neuroinflammation in vascular cognitive impairment and dementia: current evidence, advances, and prospects[J]. Int J Mol Sci, 2022, 23(11): 6224.
[5] ZHANG L Y, PAN J, MAMTILAHUN M, et al. Microglia exacerbate white matter injury via complement C3/C3aR pathway after hypoperfusion[J]. Theranostics, 2020, 10(1): 74-90.
[6] MIYAMOTO N, MAGAMI S, INABA T, et al. The effects of A1/A2 astrocytes on oligodendrocyte linage cells against white matter injury under prolonged cerebral hypoperfusion[J]. Glia, 2020, 68(9): 1910-1924.
[7] FÜNFSCHILLING U, SUPPLIE L M, MAHAD D, et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity[J]. Nature, 2012, 485(7399): 517-521.
[8] HOU X, LIANG X, CHEN J F, et al. Ecto-5′-nucleotidase (CD73) is involved in chronic cerebral hypoperfusion-induced white matter lesions and cognitive impairment by regulating glial cell activation and pro-inflammatory cytokines[J]. Neuroscience, 2015, 297: 118-126.
[9] SEO J H, MIYAMOTO N, HAYAKAWA K, et al. Oligodendrocyte precursors induce early blood-brain barrier opening after white matter injury[J]. J Clin Invest, 2013, 123(2): 782-786.
[10] BJERKE M, ZETTERBERG H, EDMAN Å, et al. Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer’s disease[J]. J Alzheimers Dis, 2011, 27(3): 665-676.
[11] ZHAO J, BI W, XIAO S, et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice[J]. Sci Rep, 2019, 9(1): 5790.
[12] MOTAGHINEJAD M, MOTEVALIAN M, FATIMA S, et al. The neuroprotective effect of curcumin against nicotine-induced neurotoxicity is mediated by CREB-BDNF signaling pathway[J]. Neurochem Res, 2017, 42(10): 2921-2932.
[13] NI P, DONG H, ZHOU Q, et al. Preoperative sleep disturbance exaggerates surgery-induced neuroinflammation and neuronal damage in aged mice[J]. Mediators Inflamm, 2019, 2019: 8301725.
[14] ANDERSON R M, GLANZ R M, JOHNSON S B, et al. Prolonged corticosterone exposure induces dendritic spine remodeling and attrition in the rat medial prefrontal cortex[J]. J Comp Neurol, 2016, 524(18): 3729-3746.
[15] QUAN C, CHEN J, LUO Y, et al. BIS-guided deep anesthesia decreases short-term postoperative cognitive dysfunction and peripheral inflammation in elderly patients undergoing abdominal surgery[J]. Brain Behav, 2019, 9(4): e01238.
[16] KABADI S V, STOICA B A, ZIMMER D B, et al. S100B inhibition reduces behavioral and pathologic changes in experimental traumatic brain injury[J]. J Cereb Blood Flow Metab, 2015, 35(12):2010-2020.
[17] MIZUSHIMA H, ZHOU C J, DOHI K, et al. Reduced postischemic apoptosis in the hippocampus of mice deficient in interleukin-1[J]. J Comp Neurol, 2002, 448(2): 203-216.
[18] RUIZ DE MORALES J M G, PUIG L, DAUDÉN E, et al. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: an updated review of the evidence focusing in controversies[J]. Autoimmun Rev, 2020, 19(1): 102429.
[19] BAUD V, KARIN M. Signal transduction by tumor necrosis factor and its relatives[J]. Trends Cell Biol, 2001, 11(9): 372-377.
[20] DEGOS V, VACAS S, HAN Z, et al. Depletion of bone marrow-derived macrophages perturbs the innate immune response to surgery and reduces postoperative memory dysfunction[J]. Anesthesiology, 2013, 118(3): 527-536.
[21] MCALPINE C S, PARK J, GRICIUC A, et al. Astrocytic interleukin-3 programs microglia and limits Alzheimer’s disease[J]. Nature, 2021, 595(7869): 701-706.
[22] BABCOCK A A, ILKJÆR L, CLAUSEN B H, et al. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice[J]. Brain Behav Immun, 2015, 48: 86-101.
[23] LU Y, ZHOU M, LI Y, et al. Minocycline promotes functional recovery in ischemic stroke by modulating microglia polarization through STAT1/STAT6 pathways[J]. Biochem Pharmacol, 2021, 186: 114464.
[24] MOONEN S, KOPER M J, VAN SCHOOR E, et al. Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neurons[J]. Acta Neuropathol, 2023, 145(2): 175-195.
[25] VAN ZELLER M, DIAS D, SEBASTIÃO A M, et al. NLRP3 inflammasome: a starring role in amyloid-β- and tau-driven pathological events in Alzheimer’s disease[J]. J Alzheimers Dis, 2021, 83(3): 939-961.
[26] SAWIKR Y, YARLA N S, PELUSO I, et al. Neuroinflammation in Alzheimer’s disease: the preventive and therapeutic potential of polyphenolic nutraceuticals[J]. Adv Protein Chem Struct Biol, 2017, 108: 33-57.
[27] CALSOLARO V, EDISON P. Neuroinflammation in Alzheimer’s disease: current evidence and future directions[J]. Alzheimers Dement, 2016, 12(6): 719-732.
[28] XUE F, DU H. TREM2 mediates microglial anti-inflammatory activations in Alzheimer’s disease: lessons learned from transcriptomics[J]. Cells, 2021, 10(2): 321.
[29] ALATA W, YE Y, ST-AMOUR I, et al. Human apolipoprotein E4 expression impairs cerebral vascularization and blood-brain barrier function in mice.[J]. J Cereb Blood Flow Metab, 2015, 35(1):86-94.

Research progress of inflammation and cognitive impairment

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Recommended 10

[1]	WANG Qi, WANG Zhe, WANG Yuehui. Research progress on inflammation and sleep disorders [J]. Practical Geriatrics, 2025, 39(6): 543-546.
[2]	DENG Chaowei, LIU Danli, YE Xujun. Inflammation and common geriatric syndromes: research progress with a focus on hearing impairment [J]. Practical Geriatrics, 2025, 39(6): 551-554.
[3]	LAI Shuyuan, YU Shuping, YAN Lirong, GUI Qiliang, CHEN Feng. Correlation between cognitive impairment and ability of the elderly in nursing institution [J]. Practical Geriatrics, 2025, 39(4): 377-381.
[4]	AN Fangjie, LIU Ying, ZHAO He. Relationship between pan-immune-inflammation index and the severity of diabetic retinopathy with macular edema in elderly patients [J]. Practical Geriatrics, 2025, 39(4): 387-390.
[5]	WANG Yan, XU Jie, GU Xiaoping. Research advances on association between fatty acid metabolism and Alzheimer’s disease [J]. Practical Geriatrics, 2025, 39(4): 415-419.
[6]	LIN Xiaoqi, ZHAO Xinjing, WU Yashuang, ZHAO Wei, CHEN Chen, GAO Tianyu, ZHOU Guoyu. Advances of the mechanisms of gender differences in Alzheimer’s disease [J]. Practical Geriatrics, 2025, 39(4): 420-425.
[7]	ZHANG Yue, LIU Wen, ZHOU Zhiqiang. Correlation between preoperative peripheral inflammation phenotypes and postoperative delirium in elderly patients: a latent class analysis based on inflammatory markers [J]. Practical Geriatrics, 2025, 39(3): 236-240.
[8]	CUI Yin, ZHANG Fujun, MA Zhengliang, GU Xiaoping. Development trajectory of cognitive function in elderly patients undergoing robot-assisted laparoscopic urological surgery [J]. Practical Geriatrics, 2025, 39(3): 282-285.
[9]	WANG Siya, YIN Shi. Effects of environmental exposure on cognitive impairment [J]. Practical Geriatrics, 2025, 39(1): 22-25.
[10]	DAI Jing, CUI Yan. Correlation between glycosylated hemoglobin variability and cognitive dysfunction in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(9): 931-935.
[11]	YE Niansi, HU Hui, DENG Bei, LIU Xueting, ZHOU Shi, LI Yucan, WANG Xiaomeng. Current situation and influencing factors of oral health-related quality of life in elderly with mild cognitive impairment [J]. Practical Geriatrics, 2024, 38(7): 674-678.
[12]	LIU Tian, YANG Rongli, HAN Huiping. Value of serum levels of Aβ1-42 and Bcl-2 in predicting the pathogenesis of Alzheimer’s disease in elderly patients with cognitive impairment [J]. Practical Geriatrics, 2024, 38(6): 582-586.
[13]	SHI Wen, ZHU Ping, ZHOU Jie, YAN Ting, HUANG Yujie, YAN Yan. Effect of pancreatic kallidinogenase on mild cognitive impairment in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(6): 587-591.
[14]	YOU Jiaxiang, LI Xiaoxi, XIA Jun, LI Haopeng, WANG Jun. Predictive value of hypoperfusion intensity ratio combined with systemic immune-inflammation index for early neurological deterioration after thrombolysis in elderly patients with acute ischemic stroke [J]. Practical Geriatrics, 2024, 38(6): 598-602.
[15]	WEI qian, CAI Yingyuan, WANG Shan,TAN Fuyun, LU Xiaowei. Relationship between serum thyrotropin and risk of cognitive impairment in elderly with normalthyroid function and subclinical hypothyroidism [J]. Practical Geriatrics, 2024, 38(5): 486-437.